Week in review: New IOP-lowering drops, post-lockdown intravitreal injections, air pollution and glaucoma
- Posted on: Sep 27 2022
- Leave a response
This week in the news, the FDA approves a first-in-class treatment for lowering IOP, post-lockdown intravitreal injection challenges remain, and air pollution worsens the risk of acute glaucoma.
Source: AAO
Posted in: Uncategorized